EP08.02-103 Lorlatinib for ALK+ NSCLC Patients Pretreated with Second-Generation ALK Inhibitors: Canadian Real-World Experience
| Autor: | R. Ng, C. Zuraik, P.V. On, S. Khoudigian, A. Sharma, F. Peloquin, F. Fanton Aita, M. Rupp |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Journal of Thoracic Oncology. 17:S450 |
| ISSN: | 1556-0864 |
| DOI: | 10.1016/j.jtho.2022.07.786 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|